Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Khian Aun Tan, Monique M. Ryan, Rachel A. Kennedy, Kate Carroll, Katy de Valle, Carrie M. Kollias, Eppie M. Yiu |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study
par: T. Rehbein, et autres
Publié: (2024)
par: T. Rehbein, et autres
Publié: (2024)
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease
par: Ah Jin Lee, et autres
Publié: (2025)
par: Ah Jin Lee, et autres
Publié: (2025)
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease
par: Anthony Maino, et autres
Publié: (2025)
par: Anthony Maino, et autres
Publié: (2025)
Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure
par: Pimchanok Kulsirichawaroj, et autres
Publié: (2025)
par: Pimchanok Kulsirichawaroj, et autres
Publié: (2025)
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A
par: Ester da Silva Estevam, et autres
Publié: (2025)
par: Ester da Silva Estevam, et autres
Publié: (2025)
Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease
par: Kayla M. D. Cornett, et autres
Publié: (2025)
par: Kayla M. D. Cornett, et autres
Publié: (2025)
A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing
par: Bianca R. Grosz, et autres
Publié: (2024)
par: Bianca R. Grosz, et autres
Publié: (2024)
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes
par: Endrit Shumeri, et autres
Publié: (2025)
par: Endrit Shumeri, et autres
Publié: (2025)
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A
par: Isaac R. L. Xu, et autres
Publié: (2024)
par: Isaac R. L. Xu, et autres
Publié: (2024)
Correction to “Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes”
Publié: (2025)
Publié: (2025)
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?
par: Moez Ravanbod, et autres
Publié: (2025)
par: Moez Ravanbod, et autres
Publié: (2025)
Genotype–phenotype correlations of AR‐CMT2S in a cohort of axonal Charcot–Marie–Tooth patients from Central South China
par: Lei Liu, et autres
Publié: (2024)
par: Lei Liu, et autres
Publié: (2024)
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation
par: Zhongzheng Li, et autres
Publié: (2024)
par: Zhongzheng Li, et autres
Publié: (2024)
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases
par: Courtney L. Hatton, et autres
Publié: (2025)
par: Courtney L. Hatton, et autres
Publié: (2025)
Neurofilament Light Chain Levels in a Large Idiopathic Peripheral Neuropathy Cohort
par: Simone Thomas, et autres
Publié: (2025)
par: Simone Thomas, et autres
Publié: (2025)
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain
par: William S. Frye, et autres
Publié: (2025)
par: William S. Frye, et autres
Publié: (2025)
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort
par: Samuel Eric Chokote, et autres
Publié: (2025)
par: Samuel Eric Chokote, et autres
Publié: (2025)
ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome
par: Saif Haddad, et autres
Publié: (2025)
par: Saif Haddad, et autres
Publié: (2025)
CIDP With and Without Monoclonal Gammopathy of Undetermined Significance ( MGUS ): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response
par: R. van Veen, et autres
Publié: (2026)
par: R. van Veen, et autres
Publié: (2026)
Digenic FLNA and UCHL1 variants resulting in a complex phenotype
par: Helena F. Pernice, et autres
Publié: (2024)
par: Helena F. Pernice, et autres
Publié: (2024)
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis
par: Catherine M. Daley, et autres
Publié: (2025)
par: Catherine M. Daley, et autres
Publié: (2025)
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?
par: Stéphanie A. Eid, et autres
Publié: (2025)
par: Stéphanie A. Eid, et autres
Publié: (2025)
Impact of High‐Dose Tafamidis on Hereditary ATTR ( ATTRv ) Amyloidosis With Central Nervous System Involvement: Two Case Reports With Clinical, Radiological and Cerebrospinal Fluid Follow Up
par: Victor Jia Wei Zhang, et autres
Publié: (2025)
par: Victor Jia Wei Zhang, et autres
Publié: (2025)
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy
par: Georgios Ponirakis, et autres
Publié: (2025)
par: Georgios Ponirakis, et autres
Publié: (2025)
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT
par: Rosemary Shy, et autres
Publié: (2025)
par: Rosemary Shy, et autres
Publié: (2025)
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes
par: Georgios Ponirakis, et autres
Publié: (2024)
par: Georgios Ponirakis, et autres
Publié: (2024)
Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE‐CIDP 3 trial
par: Robert D. M. Hadden, et autres
Publié: (2024)
par: Robert D. M. Hadden, et autres
Publié: (2024)
Behavioral Thermoceptive Responses and Morphologic Correlates in Mouse Models of CMT1A , HNPP , and Aging
par: Vaibhav Oberoi, et autres
Publié: (2026)
par: Vaibhav Oberoi, et autres
Publié: (2026)
Unique Nerve Tissue‐Restricted T‐Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy
par: G. G. A. van Lieverloo, et autres
Publié: (2025)
par: G. G. A. van Lieverloo, et autres
Publié: (2025)
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla
par: Amy R. McDowell, et autres
Publié: (2024)
par: Amy R. McDowell, et autres
Publié: (2024)
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS
par: Tatiana Hamadeh, et autres
Publié: (2025)
par: Tatiana Hamadeh, et autres
Publié: (2025)
Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System
par: Svea Nolte, et autres
Publié: (2025)
par: Svea Nolte, et autres
Publié: (2025)
Pseudodominant Inheritance of Biallelic RFC1 Expansions—Revisiting the 3p22‐p24 HSN1B Locus
par: Bianca R. Grosz, et autres
Publié: (2025)
par: Bianca R. Grosz, et autres
Publié: (2025)
Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab Debate
par: Gordon Sloan, et autres
Publié: (2026)
par: Gordon Sloan, et autres
Publié: (2026)
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”
Publié: (2025)
Publié: (2025)
Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk
par: Ethan Parikh, et autres
Publié: (2026)
par: Ethan Parikh, et autres
Publié: (2026)
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers
par: Alessandro Salvalaggio, et autres
Publié: (2025)
par: Alessandro Salvalaggio, et autres
Publié: (2025)
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?
par: Norito Kokubun, et autres
Publié: (2024)
par: Norito Kokubun, et autres
Publié: (2024)
Issue Information
Publié: (2024)
Publié: (2024)
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells
par: Amanda S. Mondschein, et autres
Publié: (2025)
par: Amanda S. Mondschein, et autres
Publié: (2025)
Documents similaires
-
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study
par: T. Rehbein, et autres
Publié: (2024) -
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease
par: Ah Jin Lee, et autres
Publié: (2025) -
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease
par: Anthony Maino, et autres
Publié: (2025) -
Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure
par: Pimchanok Kulsirichawaroj, et autres
Publié: (2025) -
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A
par: Ester da Silva Estevam, et autres
Publié: (2025)